Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With MS Treated With Rituximab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab
JAMA Netw Open 2022 May 02;5(5)e2211497, A Tolf, A Wiberg, M Müller, FH Nazir, I Pavlovic, I Laurén, S Mangsbo, J BurmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.